Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).
Saved in:
| Title: | Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2). |
|---|---|
| Authors: | Takeuchi T; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan., Matsubara T; Department of Orthopedics, Matsubara Mayflower Hospital, Hyogo, Japan., Atsumi T; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan., Amano K; Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Ishiguro N; Aichi Developmental Disability Center, Aichi, Japan., Sugiyama E; Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan., Yamaoka K; Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan., Genovese MC; Gilead Sciences Inc, Foster City, CA, USA., Kalunian K; Division of Rheumatology, Allergy, and Immunology, University of California, San Diego, CA, USA., Walker D; Northumbria Healthcare, North Shields, UK., Gottenberg JE; Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France., de Vlam K; Department of Rheumatology, Universitair Ziekenhuis Leuven, Leuven, Belgium., Bartok B; Gilead Sciences Inc, Foster City, CA, USA., Pechonkina A; Gilead Sciences Inc, Foster City, CA, USA., Kondo A; Gilead Sciences K.K, Tokyo, Japan., Gao J; Gilead Sciences Inc, Foster City, CA, USA., Guo Y; Gilead Sciences Inc, Foster City, CA, USA., Tasset C; Galapagos NV, Mechelen, Belgium., Sundy JS; Gilead Sciences Inc, Foster City, CA, USA., Tanaka Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. |
| Source: | Modern rheumatology [Mod Rheumatol] 2022 Jan 05; Vol. 32 (1), pp. 59-67. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN: 1439-7609 (Electronic) Linking ISSN: 14397595 NLM ISO Abbreviation: Mod Rheumatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1439-7609 |
|---|---|
| DOI: | 10.1080/14397595.2020.1859675 |
